New metabolites of di(2-ethylhexyl)phthalate (DEHP) in human urine and serum after single oral doses of deuterium-labelled DEHP

被引:438
作者
Koch, HM
Bolt, HM
Preuss, R
Angerer, J
机构
[1] Univ Erlangen Nurnberg, Inst & Outpatient Clin Occupat Social & Environm, D-91054 Erlangen, Germany
[2] Univ Dortmund, Leibniz Res Ctr Working Environm & Human Factors, Inst Occupat Physiol, D-44139 Dortmund, Germany
关键词
metabolism; human; urine; serum; di(2-ethylhexyl)phthalate (DEHP); mono(2-ethyl-5-hydroxyhexyl)phthalate (5OH-MEHP); mono(2-ethyl-5-oxo-hexyl)phthalate (5oxo-MEHP); mono(2-ethyl-5-carboxypropyl)phthalate (5cx-MEPP); mono[2-(carboxymethyl)hexyl]phthalate (2cx-MMHP); mono(2-ethylhexyl)phthalate (MEHP);
D O I
10.1007/s00204-004-0642-4
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
The metabolism of di(2-ethylhexyl)phthalate (DEHP) in humans was studied after three doses of 0.35 mg (4.7 mu g/kg), 2.15 mg (28.7 mu g/kg) and 48.5 mg (650 mu g/kg) of D4-ring-labelled DEHP were administered orally to a male volunteer. Two new metabolites, mono(2-ethyl-5-carboxypentyl)phthalate (5cx-MEPP) and mono[2-(carboxymethyl)hexyl]phthalate (2cx-MMHP) were monitored for 44 h in urine and for 8 h in serum for the high-dose case, in addition to the three metabolites previously analysed: mono(2-ethyl-5-hydroxyhexyl)phthalate (5OH-MEHP), mono(2-ethyl-5-oxohexyl)phthalate (5oxo-MEHP) and mono(2-ethylhexyl)phthalate (MEHP). For the medium- and low-dose cases, 24 h urine samples were analysed. Up to 12 h after the dose, 5OH-MEHP was the major urinary metabolite, after 12 h it was 5cx-MEPP, and after 24 h it was 2cx-MMHP. The elimination half-lives of 5cx-MEHP and 2cx-MMHP were between 15 and 24 h. After 24 h 67.0% (range: 65.8-70.5%) of the DEHP dose was excreted in urine, comprising 5OH-MEHP (23.3%), 5cx-MEPP (18.5%), 5oxo-MEHP (15.0%), MEHP (5.9%) and 2cx-MMHP (4.2%). An additional 3.8% of the DEHP dose was excreted on the second day, comprising 2cx-MMHP (1.6%), 5cx-MEPP (1.2%), 5OH-MEHP (0.6%) and 5oxo-MEHP (0.4%). In total about 75% of the administered DEHP dose was excreted in urine after two days. Therefore, in contrast to previous studies, most of the orally administered DEHP is systemically absorbed and excreted in urine. No dose dependency in metabolism and excretion was observed. The secondary metabolites of DEHP are superior biomonitoring markers compared to any other parameters, such as MEHP in urine or blood. 5OH-MEHP and 5oxo-MEHP in urine reflect short-term and 5cx-MEHP and 2cx-MMHP long-term exposure. All secondary metabolites are unsusceptible to contamination. Furthermore, there are strong hints that the secondary oxidised DEHP metabolites-not DEHP or MEHP-are the ultimate developmental toxicants.
引用
收藏
页码:367 / 376
页数:10
相关论文
共 36 条
[11]   Environmental anti-androgens and male reproductive health: focus on phthalates and testicular dysgenesis syndrome [J].
Fisher, JS .
REPRODUCTION, 2004, 127 (03) :305-315
[12]   (2-Ethyl-5-oxo-hexyl) methylthiomethyl phthalate as by-product of the Swern oxidation:: Improved synthesis of ring-deuterated major metabolites of bis(2-ethylhexyl) phthalate [J].
Gilsing, HD ;
Angerer, J ;
Prescher, D .
MONATSHEFTE FUR CHEMIE, 2003, 134 (09) :1207-1213
[13]   Monophthalates with oxidized C5-carbon in the ester chain: A simple synthetic access to two major metabolites of bis-(2-ethylhexyl)-phthalate [J].
Gilsing, HD ;
Angerer, J ;
Prescher, D .
MONATSHEFTE FUR CHEMIE, 2002, 133 (08) :1147-1155
[14]  
GILSING HD, 2005, IN PRESS MONATSH CHE
[15]   Mono(2-ethyl-5-hydroxyhexyl) phthalate and mono-(2-ethyl-5-oxohexyl) phthalate as biomarkers for human exposure assessment to di-(2-ethylhexyl) phthalate [J].
Kato, K ;
Silva, MJ ;
Reidy, JA ;
Hurtz, D ;
Malek, NA ;
Needham, LL ;
Nakazawa, H ;
Barr, DB ;
Calafat, AM .
ENVIRONMENTAL HEALTH PERSPECTIVES, 2004, 112 (03) :327-330
[16]   Quantitative detection of nine phthalate metabolites in human serum using reversed-phase high-performance liquid chromatography-electrospray ionization-tandem mass Spectrometry [J].
Kato, K ;
Silva, MJ ;
Brock, JW ;
Reidy, JA ;
Malek, NA ;
Hodge, CC ;
Nakazawa, H ;
Needham, LL ;
Barr, DB .
JOURNAL OF ANALYTICAL TOXICOLOGY, 2003, 27 (05) :284-289
[17]  
Kavlock R, 2002, REPROD TOXICOL, V16, P529, DOI 10.1016/S0890-6238(02)00032-1
[18]   Blood burden of di(2-ethylhexyl) phthalate and its primary metabolite mono (2-ethylhexyl) phthalate in pregnant and nonpregnant rats and marmosets [J].
Kessler, W ;
Numtip, W ;
Grote, K ;
Csanády, GA ;
Chahoud, I ;
Filser, JG .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 2004, 195 (02) :142-153
[19]   Di(2-ethylhexyl)phthalate (DEHP) metabolites in human urine and serum after a single oral dose of deuterium-labelled DEHP [J].
Koch, HM ;
Bolt, HM ;
Angerer, J .
ARCHIVES OF TOXICOLOGY, 2004, 78 (03) :123-130
[20]   Internal exposure of nursery-school children and their parents and teachers to di(2-ethylhexyl)phtha late (DEHP) [J].
Koch, HM ;
Drexler, H ;
Angerer, J .
INTERNATIONAL JOURNAL OF HYGIENE AND ENVIRONMENTAL HEALTH, 2004, 207 (01) :15-22